Inventor
GUZZO PETER R
US28 patents
⚠️ This page may combine multiple inventors who share the name “GUZZO PETER R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GUZZO PETER R
9 patentsUS8710046B2Apr 29, 2014
5-HT3 receptor modulators, methods of making, and use thereof
GUZZO PETER R0 citations50
US9073925B2Jul 7, 2015
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
GUZZO PETER R0 citations40
US8618299B2Dec 31, 2013
Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
GUZZO PETER R0 citations39
US9096546B2Aug 4, 2015
Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GUZZO PETER R0 citations38
US8629158B2Jan 14, 2014
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
GUZZO PETER R0 citations37
US9045468B2Jun 2, 2015
2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GUZZO PETER R0 citations35
US8575186B2Nov 5, 2013
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
GUZZO PETER R0 citations34
US9067949B2Jun 30, 2015
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
GUZZO PETER R0 citations33
US8637501B2Jan 28, 2014
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
GUZZO PETER R0 citations32
ALBANY MOLECULAR RES INC
7 patentsUS7956050B2Jun 7, 2011
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC13 citations81
US9499531B2Nov 22, 2016
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC2 citations63
US9085531B2Jul 21, 2015
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC0 citations52
US9045501B2Jun 2, 2015
5-HT3 receptor modulators, methods of making, and use thereof
ALBANY MOLECULAR RES INC0 citations51
US9403776B2Aug 2, 2016
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC0 citations49
US9352049B2May 31, 2016
Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them
ALBANY MOLECULAR RES INC0 citations41
US8039453B2Oct 18, 2011
Vinca derivatives
ALBANY MOLECULAR RES INC0 citations40
MOLINO BRUCE F
4 patentsUS8236796B2Aug 7, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8227486B2Jul 24, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8791101B2Jul 29, 2014
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F1 citations59
US8741901B2Jun 3, 2014
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F0 citations51
CHEN DAVID
3 patentsUS8193228B2Jun 5, 2012
Substituted imidazole as bombesin receptor subtype-3 modulators
CHEN DAVID4 citations60
US8318767B2Nov 27, 2012
Substituted imidazoles as bombesin receptor subtype-3 modulators
CHEN DAVID0 citations50
US8106070B2Jan 31, 2012
Substituted imidazoles as bombesin receptor subtype-3 modulators
CHEN DAVID0 citations50